Public Company News
Taoping Signs Non-binding Letter of Intent to Acquire Yunti; Transformational Acquisition Would Substantially Improve Taoping's Annual Revenue, Expand its Addressable Market, and Leverage its Current Portfolio
SHENZHEN, China, Dec. 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, new media and artificial intelligence (AI) solutions, today announced that it has signed a non-binding letter of intent to acquire 100% o...
2024-12-09 21:30
3463
Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial
* Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 * Appoints US-based Chief Commercial Officer, Andrew Udell * Xanamem's unique ability to control brain cortisol draws widespread coverage in the Australian media. SYDNEY, Dec. 9, 2024 /PRNewswire/ -- A...
2024-12-09 21:00
2804
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
BEIJING, Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that the National Medical Products Administration of...
2024-12-09 20:30
2751
Noah Showcases Global Expansion and Investment Product Leadership at 2024 Corporate Open Day
* Accelerating global expansion into emerging markets with new brands * Global investment allocation strategies and expanded product offerings drive long-term value for clients * Expanding comprehensive service matrix to address evolving client needs globally SHANGHAI, Dec. 9, 2024 /PRNewswi...
2024-12-09 19:00
2972
Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-cell Non-Hodgkin Lymphoma at the 2024 ASH Annual Meeting
DZD8586 demonstrated encouraging anti-tumor activity with manageable safety and favorable pharmacokinetic (PK) characteristics in patients with B-NHL SHANGHAI, Dec. 9, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment o...
2024-12-09 18:00
2131
iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users
BEIJING, Dec. 9, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, recently launched a new 'Extra Large Font' function on its app, offering a comprehensive suite of accessibility features tailored for senior users and the visual requirements of a broader audience. With ju...
2024-12-09 17:05
2667
Acer Announces November Revenues at NT$22.75 Billion, Up 20.9% Month-on-month and 13.1% Year-on-year
TAIPEI, Dec. 9, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for November atNT$22.75 billion with 20.9% growth month-on-month and 13.1% growth year-on-year (YoY). Consolidated revenues for year-to-November revenues reachedNT$240.16 billion with 10.4% growth YoY....
2024-12-09 16:44
2140
Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2024
BEIJING, Dec. 9, 2024 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading player in mainlandChina's online social networking space, today announced its unaudited financial results for the third quarter of 2024. Third Quarter of 2024 Highlights * Net r...
2024-12-09 16:16
2533
2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting
SHANGHAI, Dec. 8, 2024 /PRNewswire/ -- December 8, 2024, Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2 study results for pimicotinib (ABSK021) in patients with chronic Graft-versus-Host Disease (cGvHD) who have either progressed or not responded to one or mo...
2024-12-09 10:40
2236
Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH
BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company dedicated to developing therapies toward undruggable targets, today presented preliminary Phase I data of BET inhibitor JAB-8263 to treat myelofibrosis (MF) at the 2024 ASH (Ame...
2024-12-09 08:42
2069
Caliway Biopharmaceuticals Included in FTSE TWSE Taiwan Eight Industries and Mid-Cap 100 Indices
NEW TAIPEI CITY, Dec. 6, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals Co., Ltd. (TWSE-6919) is proud to announce its inclusion in the FTSE TWSE Taiwan Mid-Cap 100 Index and the FTSE TWSE Taiwan Eight Industries Index, two prestigious benchmarks jointly compiled by FTSE Russell and the Taiwan S...
2024-12-07 08:57
4239
Baijiayun Announces Up To $15 Million Convertible Promissory Notes And $50 Million Standby Equity Purchase Agreement
BEIJING, Dec. 6, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced that it has entered into a Standby Equity Purchase Agreement (the "SEPA"), with YA II PN, Ltd. ("YA"), a fund managed by Yorkville Advisor...
2024-12-07 06:00
17340
JXJT First Half Year Financial Report 2024: Achieved 30% Revenue Surge and Strong Profit Growth
HAIKOU, China, Dec. 6, 2024 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: JXJT) (the "Company"), a technology company engages in integrated tourism services, including tourism, duty-free cross-border goods, and comprehensive e-commerce technology solutions, today announced financial results for ...
2024-12-06 22:28
5405
Marvion Inc. Announces Application Submission to Quote on OTCQB® Venture Market Providing Direct Path to Liquidity for Investors
HONG KONG, Dec. 6, 2024 /PRNewswire/ -- Marvion Inc. (OTC: MVNC), a logistics and storage services company dedicated to deliver one stop logistics, storage and distribution services to B2B customers inHong Kong such as FedEx, SF Express, etc, today announced that it has submitted the necessary ap...
2024-12-06 21:08
4640
Hesai Announces Exclusive Lidar Design Win for Multiple Great Wall Motor Models
SHANGHAI, Dec. 6, 2024 /PRNewswire/ -- Today, Hesai Technology (NASDAQ: HSAI), the global leader in lidar solutions, announced an exclusive series production design win with Great Wall Motor, covering several models across its two brands. These models will feature Hesai's ATX, an ultra-compact hi...
2024-12-06 20:30
3780
Mega Matrix Announces that Urban Romance Short Drama "My Sugar Baby Turns Out to be NYC's Richest Man" Premieres on December 10
SINGAPORE, Dec. 6, 2024 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), today announced that it will premiereMy Sugar Baby Turns Out to be NYC's Richest Man on December 10. Money, a force that can both propel and destroy, takes center stage in a story of shifting f...
2024-12-06 18:30
3738
CNFinance Announces Change of Auditor
GUANGZHOU, China, Dec. 6, 2024 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider inChina, today announced the dismissal of KPMG Huazhen LLP ("KPMG"), the Company's independent registered public accounting firm, and a...
2024-12-06 18:00
3078
Jinxin Technology Holding Company Announces Pricing of US$5 Million Initial Public Offering
SHANGHAI, Dec. 5, 2024 /PRNewswire/ -- Jinxin Technology Holding Company (the "Company"), an innovative digital content service provider inChina, today announced the pricing of its initial public offering (the "Offering") of 1,250,000 American Depositary Shares ("ADSs") at a price to the public o...
2024-12-06 11:50
2580
USANA Malaysia Named the Top Combination Dietary Supplements and Calcium Supplements Brand by Euromonitor International
KUALA LUMPUR, Malaysia, Dec. 6, 2024 /PRNewswire/ -- USANA Malaysia was recently awarded the title Top #1 Combination Dietary and Calcium Supplements Brand inMalaysia by market research giant Euromonitor International. This marks the sixth consecutive year the market received the combination diet...
2024-12-06 07:52
2983
Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care
Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations to transform global cancer care SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- At this year's RSNA 2024 Annual Meeting, Lunit (KRX:328130.KQ),...
2024-12-05 22:07
2924
Week's Top Stories
Most Reposted
UFO SIM Launches in Australia, The Ultimate Travel eSIM Starting at Just AU$2/GB
[Picked up by 310 media titles]
2026-04-01 11:03
Sustainable Tourism Impact Fund Expands Investments Across Southeast Asia
[Picked up by 309 media titles]
2026-04-03 11:30
Surfin Meta Digital Technology signs MOU with the Philippine Social Security System to explore digital financial service enhancements
[Picked up by 307 media titles]
2026-04-01 09:00
Visa cements global K-pop connection as Worldwide Tour Sponsor for "BTS WORLD TOUR 'ARIRANG'"
[Picked up by 303 media titles]
2026-04-06 10:00
From Doomscroll to Page-Turner: BookXcess Launches The Brain Un-Rot Library to Help Rebuild a Generation's Focus
[Picked up by 302 media titles]
2026-03-31 13:53
Most Read
NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade
2026-04-01 22:44
5711
